Patents by Inventor Jacqueline Ameri

Jacqueline Ameri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ISOLATION OF BONA FIDE PANCREATIC PROGENITOR CELLS
    Publication number: 20230227788
    Abstract: The present invention relates to a method for isolating bona fide pancreatic progenitor cells and to cell populations enriched for bona fide pancreatic progenitor cells.
    Type: Application
    Filed: February 27, 2023
    Publication date: July 20, 2023
    Inventors: Jacqueline Ameri, Henrik Semb
  • Isolation of bona fide pancreatic progenitor cells
    Patent number: 11613736
    Abstract: The present invention relates to a method for isolating bona fide pancreatic progenitor cells and to cell populations enriched for bona fide pancreatic progenitor cells.
    Type: Grant
    Filed: October 15, 2019
    Date of Patent: March 28, 2023
    Assignee: University of Copenhagen
    Inventors: Jacqueline Ameri, Henrik Semb
  • GENERATION OF GLUCOSE-RESPONSIVE BETA CELLS
    Publication number: 20210301259
    Abstract: The present invention relates to a method for generating glucose-responsive beta cells.
    Type: Application
    Filed: June 10, 2021
    Publication date: September 30, 2021
    Inventors: Jacqueline Ameri, Henrik Semb
  • Generation of glucose-responsive beta cells
    Patent number: 11060062
    Abstract: The present invention relates to a method for generating glucose-responsive beta cells.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: July 13, 2021
    Assignee: University of Copenhagen
    Inventors: Jacqueline Ameri, Henrik Semb
  • Isolation Of Bona Fide Pancreatic Progenitor Cells
    Publication number: 20200080062
    Abstract: The present invention relates to a method for isolating bona fide pancreatic progenitor cells and to cell populations enriched for bona fide pancreatic progenitor cells.
    Type: Application
    Filed: October 15, 2019
    Publication date: March 12, 2020
    Inventors: Jacqueline Ameri, Henrik Semb
  • Isolation of bona fide pancreatic progenitor cells
    Patent number: 10494608
    Abstract: The present invention relates to a method for isolating bona fide pancreatic progenitor cells and to cell populations enriched for bona fide pancreatic progenitor cells.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: December 3, 2019
    Assignee: University of Copenhagen
    Inventors: Jacqueline Ameri, Henrik Semb
  • Generation Of Glucose-Responsive Beta Cells
    Publication number: 20190127703
    Abstract: The present invention relates to a method for generating glucose-responsive beta cells.
    Type: Application
    Filed: December 22, 2017
    Publication date: May 2, 2019
    Inventors: Jacqueline Ameri, Henrik Semb
  • ISOLATION OF BONA FIDE PANCREATIC PROGENITOR CELLS
    Publication number: 20180127724
    Abstract: The present invention relates to a method for isolating bona fide pancreatic progenitor cells and to cell populations enriched for bona fide pancreatic progenitor cells.
    Type: Application
    Filed: April 21, 2016
    Publication date: May 10, 2018
    Inventors: Jacqueline Ameri, Henrik Semb
  • INDUCED DERIVATION OF SPECIFIC ENDODERM FROM hPS CELL-DERIVED DEFINITIVE ENDODERM
    Publication number: 20120135519
    Abstract: The present invention relates to a method to control differentiation of human pluripotent stem cells, including human balstocyst derived stem (hBS) cells and to obtain specific endoderm cells. In particular, present invention relates to the use of FGF2 as the key factor in a specific concentration to control differentiation of definitive endoderm cells derived from hPS cells to specific endoderm cells. The invention also provides methods of obtaining endoderm cells comprising the use of FGFR and activation of the MAPK signalling pathway.
    Type: Application
    Filed: May 28, 2010
    Publication date: May 31, 2012
    Applicants: Cellartis AB, Novo Nordisk A/S
    Inventors: Jacqueline Ameri, Henrik Semb